Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

NCT: NCT06423430 · RECRUITING

NCT IDNCT06423430
StatusRECRUITING
Start Date2024-09-11
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to evaluate the effectiveness and safety of bilateral stimulation of the subcallosal cingulate white matter (SCCwm) using Deep Brain Stimulation (DBS) as an adjunctive treatment of non-psychotic unipolar Major Depressive Disorder (MDD) in adults.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑